by Alexandre Soulier, Lila Poiteau, Isabelle Rosa et al.
J Infect Dis. (2016) 213 (7): 1087-1095. – First published online: September 2, 2015
With the advent of highly efficient antiviral therapies for hepatitis C virus (HCV) infection, providing broad access to diagnosis and care is needed. The dried blood spot (DBS) technique can be used to collect, store, and ship whole-blood specimens. The goal was to assess the performance of standardized HCV diagnostic and monitoring tools in the analysis of DBS. This study shows that whole-blood specimens collected using the DBS technique can be confidently used to diagnose and monitor HCV infection. DBS could help improve access to care for HCV infection because they are suitable for use in large-scale screening programs, diagnosis, and therapeutic monitoring.